Pathways used by relaxin to regulate myometrial phospholipase C.
Relaxin exhibits pleiotropic effects on reproductive and nonreproductive tissues; the signaling mechanisms underlying these functions are still not well understood. Activation of protein kinase A and several other signal-regulated protein kinases results in the phosphorylation of phospholipase C (PLC)-beta3 and inhibit Galpha(q)-stimulated PLC activity. Therefore, PLCbeta3 may be targeted by both contractant and relaxant signaling pathways in myometrium and play a critical role in the balance between them. PHM1 cells express mRNA for relaxin receptor LGR7, and relaxin inhibits oxytocin-stimulated PLC activity in these cells. Thus, this model system may be useful in delineating signaling pathways used by relaxin. Here, we present evidence that relaxin stimulates phosphorylation of PLCbeta3 in PHM1 cells.
Zhong
Miao
M
Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Ku
Chun-Ying
CY
Sanborn
Barbara M
BM
D000595:Amino Acid Sequence; D000818:Animals; D002460:Cell Line; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000737:chemistry / Q000378:metabolism*; D008954:Models, Biological; D008969:Molecular Sequence Data; D009215:Myometrium / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D054799:Phospholipase C beta; D010766:Phosphorylation / Q000187:drug effects; D012065:Relaxin / Q000494:pharmacology*; D016415:Sequence Alignment; D015398:Signal Transduction / Q000187:drug effects*; D010738:Type C Phospholipases / Q000737:chemistry / Q000378:metabolism*
D007527:Isoenzymes; D012065:Relaxin; D010738:Type C Phospholipases; C518039:PLCB3 protein, human; D054799:Phospholipase C beta